Verano Holdings Corp (VRNO) stock news · rev $821.5M
Verano Holdings Corp (VRNO) is a drug manufacturers - specialty & generic company listed on OTCQX.
This VRNO news page leads with what Verano Holdings Corp filed — not a scraped headline mill.
No cached 8-K sentence for VRNO yet. We will not pad this page with generic market recap.
Latest reported VRNO revenue for 2025-12-31 was $821.5M. Net income was -$257.9M. Revenue was down 6.5% from 2024-12-31 to 2025-12-31. VRNO currently screens at market cap $432.4M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the VRNO stock page; for the tape open the quote page.
Not investment advice.